Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dayu Shi

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
British Journal of Clinical Pharmacology|January 21, 2025
Pharmacokinetic characterization and exposure-response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuriaValérie Cosson, Rong Fu, Austin Kulasekararaj, et al.
Leukemia & Lymphoma|June 8, 2021
Variables associated with patient-reported outcomes in patients with myeloproliferative neoplasmsDayu Shi, Hongxia Shi, Xiaoli Liu, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
British Journal of Clinical Pharmacology|January 21, 2025
Pharmacokinetic characterization and exposure-response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuriaValérie Cosson, Rong Fu, Austin Kulasekararaj, et al.
Leukemia & Lymphoma|June 8, 2021
Variables associated with patient-reported outcomes in patients with myeloproliferative neoplasmsDayu Shi, Hongxia Shi, Xiaoli Liu, et al.
Pageof 2